TECH
Bio-Techne Corporation
Biotechnology · Healthcare · United States
72.17
close · 2026-08-13
value
39
cheaper than peers39
quality
74
stronger fundamentals74
ranked against
Biotechnology (commercial)
value
quality
101 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 9.29× | 61 |
| price to book | 5.42× | 52 |
| EV to EBITDA | 31.07× | 39 |
| forward P/E | 31.23× | 27 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 25.2% | 85 |
| return on equity | 5.3% | 75 |
| debt to equity | 13.9% | 58 |
| revenue growth | -1.5% | 29 |
4 of 4 measures available
Facts
| market cap | $11B |
| free cash flow | $299.8M |
| employees | 3,100 |
| first trade | 1989-02-09 |
| next earnings | 2026-08-12 |
| fundamentals updated | 2026-08-12 |